Jung Choi, MD, PhD

Dr. Choi received his MD and PhD from the New York University School of Medicine. He completed his radiology residency at the UCLA Medical Center and a body radiology fellowship at the Stanford University Medical Center.

Education & Training

Fellowship:

• Stanford University Medical Center - Body Imaging Radiology Fellowship

Residency:

• UCLA School of Medicine - Radiological Sciences

Medical School:

• New York University - MD

• Abudalou S, Choi J, Gage K, Pow-Sang J, Yilmaz Y, Balagurunathan Y. Challenges in Using Deep Neural Networks Across Multiple Readers in Delineating Prostate Gland Anatomy. J Imaging Inform Med. 2025 May. Pubmedid: 40392414.
• Balagurunathan Y, Choi JW, Thompson Z, Jain M, Locke FL. Radiomic Features Prognosticate Treatment Response in CAR-T Cell Therapy. Cancers (Basel). 2025 May.17(11). Pubmedid: 40507312. Pmcid: PMC12153729.
• Avasthi KK, Choi JW, Glushko T, Manley BJ, Yu A, Park JY, Brown JS, Pow-Sang J, Gatenby R, Wang L, Balagurunathan Y. Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot Study. Cancers (Basel). 2025 Feb.17(5). Pubmedid: 40075682. Pmcid: PMC11898942.
• Balagurunathan Y, Wei Z, Qi J, Thompson Z, Dean E, Lu H, Vardhanabhuti S, Corallo S, Choi JW, Kim JJ, Mattie M, Jain M, Locke FL. Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy. Front Oncol. 2024 Nov.14:1485039. Pubmedid: 39659779. Pmcid: PMC11629080.
• Wei Z, Iluppangama M, Qi J, Choi JW, Yu A, Gage K, Chumbalkar V, Dhillon J, Balaji KC, Venkataperumal S, Hernandez DJ, Park J, Yedjou C, Alo R, Gatenby RA, Pow-Sang J, Balagurunanthan Y. Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate Cancer. Cancer Control. 2024 Jan.31. Pubmedid: 39545376. Pmcid: PMC11565616.
• Avasthi KK, Choi J, Glushko T, Manley BJ, Yu A, Pow-Sang J, Gatenby R, Wang L, Balagurunathan Y. Extracellular microvesicle microRNAs, along with imaging metrics, improve detection of aggressive prostate cancer. medRxiv. 2024 Aug. Pubmedid: 39228742. Pmcid: PMC11370497.
• Choi JW, Dean EA, Lu H, Thompson Z, Qi J, Krivenko G, Jain MD, Locke FL, Balagurunathan Y. Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers. Front Immunol. 2023 Feb.14:994520. Pubmedid: 36875072. Pmcid: PMC9975754.
• Zhang J, Gallaher J, Cunningham JJ, Choi JW, Ionescu F, Chatwal MS, Jain R, Kim Y, Wang L, Brown JS, Anderson AR, Gatenby RA. A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer. Cancers (Basel). 2022 Oct.14(21). Pubmedid: 36358643. Pmcid: PMC9656891.
• Wang S, Budzevich M, Abdalah MA, Balagurunathan Y, Choi JW. In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes. Pharmaceuticals (Basel). 2022 Feb.15(3). Pubmedid: 35337090. Pmcid: PMC8953049.
• Permuth JB, Vyas S, Li J, Chen DT, Jeong D, Choi JW. Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas. Front Oncol. 2021 Jul.11:712950. Pubmedid: 34367997. Pmcid: PMC8339963.
• Permuth JB, Dezsi KB, Vyas S, Ali KN, Basinski TL, Utuama OA, Denbo JW, Klapman J, Dam A, Carballido E, Kim DW, Pimiento JM, Powers BD, Otto AK, Choi JW, Chen DT, Teer JK, Beato F, Ward A, Cortizas EM, Whisner SY, Williams IE, Riner AN, Tardif K, Velanovich V, Karachristos A, Douglas WG, Legaspi A, Allan BJ, Meredith K, Molina-Vega MA, Bao P, St Julien J, Huguet KL, Green L, Odedina FT, Kumar NB, Simmons VN, George TJ, Vadaparampil ST, Hodul PJ, Arnoletti JP, Awad ZT, Bose D, Jiang K, Centeno BA, Gwede CK, Malafa M, Judge SM, Judge AR, Jeong D, Bloomston M, Merchant NB, Fleming JB, Trevino JG. The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer. Cancers (Basel). 2021 Feb.13(4). Pubmedid: 33671939. Pmcid: PMC7919015.
• Lu H, Parra NA, Qi J, Gage K, Li Q, Fan S, Feuerlein S, Pow-Sang J, Gillies R, Choi JW, Balagurunathan Y. Repeatability of Quantitative Imaging Features in Prostate Magnetic Resonance Imaging. Front Oncol. 2020 May.10:551. Pubmedid: 32457827. Pmcid: PMC7221156.
• El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Vishvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R. Correction: Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Brit J Cancer. 2020 Mar.122(7):1118. Pubmedid: 31937927. Pmcid: PMC7109119.
• Polk SL, Choi JW, McGettigan MJ, Rose T, Ahmed A, Kim J, Jiang K, Balagurunathan Y, Qi J, Farah PT, Rathi A, Permuth JB, Jeong D. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. World J Gastroenterol. 2020 Jun.26(24):3458-3471. Pubmedid: 32655269. Pmcid: PMC7327792.
• Wang S, Choi JW. Imaging the Vasculature of Immunodeficient Mice Using Positron Emission Tomography/computed Tomography (PET/CT) and 18F-fluorodeoxyglucose Labeled Human Erythrocytes. Bio Protoc. 2019 Oct.9(19):e3391. Pubmedid: 33654883. Pmcid: PMC7920323.
• El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Visvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Brit J Cancer. 2019 Oct.121(7):556-566. Pubmedid: 31417189. Pmcid: PMC6889319.
• Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y. Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors. Oncotarget. 2019 Mar.10(21):2113. Pubmedid: 31007853. Pmcid: PMC6459347.
• Parra NA, Lu H, Choi J, Gage K, Pow-Sang J, Gillies RJ, Balagurunathan Y. Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers. Tomography. 2019 Mar.5(1):68-76. Pubmedid: 30854444. Pmcid: PMC6403034.
• Permuth JB, Clark Daly A, Jeong D, Choi JW, Cameron ME, Chen DT, Teer JK, Barnett TE, Li J, Powers BD, Kumar NB, George TJ, Ali KN, Huynh T, Vyas S, Gwede CK, Simmons VN, Hodul PJ, Carballido EM, Judge AR, Fleming JB, Merchant N, Trevino JG. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities. Cancer Med. 2019 Jun.8(6):3314-3324. Pubmedid: 31074202. Pmcid: PMC6558500.
• Choi JW, Budzevich M, Wang S, Gage K, Estrella V, Gillies RJ. In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes. PLoS One. 2019 Jan.14(1):e0211012. Pubmedid: 30682160. Pmcid: PMC6347438.
• Li Q, Lu H, Choi J, Gage K, Feuerlein S, Pow-Sang JM, Gillies R, Balagurunathan Y. Radiological semantics discriminate clinically significant grade prostate cancer. Cancer Imaging. 2019 Dec.19(1):81. Pubmedid: 31796094. Pmcid: PMC6889697.
• Parra AN, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y. Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors. Oncotarget. 2018 Dec.9(98):37125-37136. Pubmedid: 30647849. Pmcid: PMC6324677.
• Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim J, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant N, Magliocco A, Malafa MP, Gillies R. Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Sci Rep. 2017 Sep.7(1):10484. Pubmedid: 28874676. Pmcid: PMC5585319.
• Permuth JB, Choi JW, Chen DT, Jiang K, DeNicola G, Li JN, Coppola D, Centeno BA, Magliocco A, Balagurunathan Y, Merchant N, Trevino JG, Jeong D. A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?. Cancer Biol Med. 2017 Feb.14(1):66-73. Pubmedid: 28443205. Pmcid: PMC5365183.
• Jeong D, Choi JW, Jeong K, Sokol L. CT findings associated with blastic plasmacytoid dendritic cell neoplasm: a case report. Acta Radiol Open. 2016 Jul.5(7):2058460116657688. Pubmedid: 27504192. Pmcid: PMC4963986.
• Permuth JB, Choi J, Balarunathan Y, Kim J, Chen DT, Chen L, Orcutt S, Doepker MP, Gage K, Zhang G, Latifi K, Hoffe S, Jiang K, Coppola D, Centeno BA, Magliocco A, Li Q, Trevino J, Merchant N, Gillies R, Malafa M, On Behalf Of The Florida Pancreas Collaborative . Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms. Oncotarget. 2016 Dec.7(52):85785-85797. Pubmedid: 27589689. Pmcid: PMC5349874.
• Rose T, Choi J. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. Am J Med. 2015 Sep.128(9):943-949. Pubmedid: 25820169.
• Kuppler K, Jeong D, Choi JW. Non-infectious cholecystopathy secondary to high-dose IL-2 cancer immunotherapy. Acta Radiol Open. 2015 Oct.4(10):2058460115579458. Pubmedid: 26576289. Pmcid: PMC4641551.
• Jeong D, Malalis C, Arrington JA, Field AS, Choi JW, Kocak M. Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma. Quant Imaging Med Surg. 2015 Dec.5(6):835-845. Pubmedid: 26807366. Pmcid: PMC4700247.
• Abrahams D, Jeune-Smith Y, Bode A, Baldwin M, Choi JW. Real-time ultrasound-guided needle injection of the mouse jugular vein. Curr Protoc Mouse Biol. 2014 Sep.4(3):141-150. Pubmedid: 25723964.
• Nimgaonkar A, Choi JW, Nguyen L, Triadafilopoulos G. Gastrointestinal dysmotility. Digest Dis Sci. 2012 May.57(5):1130-1133. Pubmedid: 22038542.
• Hasegawa S, Choi JW, Rao J. Single-cell detection of trans-splicing ribozyme in vivo activity. J Am Chem Soc. 2004 Jun.126(23):7158-7159. Pubmedid: 15186136.
• Choi JW, Pampeno C, Vukmanovic S, Meruelo D. Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol. 2002 Jul.26(6):575-588. Pubmedid: 12031417.
• Pampeno CL, Vallerie AM, Choi J, Meruelo NC, Meruelo D. Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol. 2001 Mar.20(3):141-148. Pubmedid: 11313017.
• Yu A, Choi J, Ohno K, Levin B, Rom WN, Meruelo D. Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol. 2000 Jul.19(7):383-388. Pubmedid: 10945228.
• Zebala JA, Choi J, Barany F. Characterization of steady state, single-turnover, and binding kinetics of the TaqI restriction endonuclease. J Biol Chem. 1992 Apr.267(12):8097-8105. Pubmedid: 1569066.
• Zebala JA, Choi J, Trainor GL, Barany F. DNA recognition of base analogue and chemically modified substrates by the TaqI restriction endonuclease. J Biol Chem. 1992 Apr.267(12):8106-8116. Pubmedid: 1569067.